Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE American - Nasdaq Real Time Price USD

IGC Pharma, Inc. (IGC)

Compare
0.2837
-0.0015
(-0.53%)
At close: April 17 at 4:00:00 PM EDT
0.2830
-0.00
(-0.25%)
After hours: April 17 at 7:55:58 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Total Revenue
1,236
1,345
911
397
898
Cost of Revenue
600
612
469
203
785
Gross Profit
636
733
442
194
113
Operating Expense
8,840
10,531
12,013
15,622
8,837
Operating Income
-8,204
-9,798
-11,571
-15,428
-8,724
Other Income Expense
-605
-3,202
65
412
-87
Pretax Income
-8,809
-13,000
-11,506
-15,016
-8,811
Net Income Common Stockholders
-8,809
-13,000
-11,506
-15,016
-8,811
Diluted NI Available to Com Stockholders
-8,809
-13,000
-11,506
-15,016
-8,811
Basic EPS
-0.12
-0.22
-0.22
-0.30
-0.21
Diluted EPS
-0.12
-0.22
-0.22
-0.30
-0.21
Basic Average Shares
72,681.2940
58,839.8680
52,576.2580
49,991.6310
41,963.3820
Diluted Average Shares
72,681.2940
58,839.8680
52,576.2580
49,991.6310
41,963.3820
Total Operating Income as Reported
-8,204
-9,798
-11,571
-15,428
-8,724
Total Expenses
9,440
11,143
12,482
15,825
9,622
Net Income from Continuing & Discontinued Operation
-8,809
-13,000
-11,506
-15,016
-8,811
Normalized Income
-8,087
-9,655
-11,506
-14,967
-8,642
EBIT
-8,204
-9,798
-11,571
-15,428
-8,724
EBITDA
-7,576
-9,161
-10,914
-14,777
-8,246
Reconciled Cost of Revenue
600
612
469
203
785
Reconciled Depreciation
628
637
657
651
478
Net Income from Continuing Operation Net Minority Interest
-8,809
-13,000
-11,506
-15,016
-8,811
Total Unusual Items Excluding Goodwill
-722
-3,345
--
-49
-169
Total Unusual Items
-722
-3,345
--
-49
-169
Normalized EBITDA
-6,854
-5,816
-10,914
-14,728
-8,077
3/31/2021 - 5/24/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

VTVT vTv Therapeutics Inc.
19.70
+4.68%
 
INAB IN8bio, Inc.
0.1609
+2.09%
 
IMRN Immuron Limited
1.8929
+11.35%
 
GBIO Generation Bio Co.
0.3921
+13.03%
 
SONN Sonnet BioTherapeutics Holdings, Inc.
1.2600
+2.44%
 
KPRX Kiora Pharmaceuticals, Inc.
2.7900
-1.06%
 
CDIO Cardio Diagnostics Holdings, Inc.
0.3899
+4.22%
 
SLRX Salarius Pharmaceuticals, Inc.
0.6770
+1.04%
 
PALI Palisade Bio, Inc.
0.7199
+2.80%
 
PTIX Protagenic Therapeutics, Inc.
0.2399
-6.65%